Carlos P. Fitzsimons

Carlos P. Fitzsimons

Auto-generated profile, based on publicly available information

Carlos P. Fitzsimons

University of Amsterdam

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2012 in Behavioural Brain Research
Verified
Journal Article
Closed access
AKAniko Korosi
Aniko Korosi
ENEva F G Naninck
Eva F G Naninck
COC.A. Oomen
C.A. Oomen
MSM. Schouten
M. Schouten
HKH. Krugers
H. Krugers
PLP.J. Lucassen
P.J. Lucassen

1 November 2013 in Trends in Neurosciences
Verified
Journal Article
Closed access
PLPaul J. Lucassen
Paul J. Lucassen
ENEva F G Naninck
Eva F G Naninck
Johannes B. van GoudoeverJohannes B. van Goudoever
Johannes B. van Goudoever
CFCarlos Fitzsimons
Carlos Fitzsimons
MJMarian Joels
Marian Joels
AKAniko Korosi
Aniko Korosi

1 September 2015 in Cold Spring Harbor Perspectives in Biology
Verified
Journal Article
Open access
PDF file
PLPaul J. Lucassen
Paul J. Lucassen
COCharlotte A. Oomen
Charlotte A. Oomen
ENEva F.G. Naninck
Eva F.G. Naninck
CFCarlos P. Fitzsimons
Carlos P. Fitzsimons
ADAnne-Marie van Dam
Anne-Marie van Dam
AKAniko Korosi
Aniko Korosi
Exposure to stress is one of the best-known negative regulators of adult neurogenesis (AN). We discuss changes in neurogenesis in relation to exposure to stress, glucocorticoid hormones, and inflammation, with a particular focus on early development and on lasting effects of stress. Although the effects of acute and mild stress on AN are generally brief and can be quickly overcome, chronic exposure or more severe forms of stress can induce longer lasting reductions in neurogenesis that can, however, in part, be overcome by subsequent exposure to exercise, drugs targeting the stress system, and some antidepressants. Exposure to stress, particularly during the sensitive period of early life, may (re)program brain plasticity, in particular, in the hippocampus. This may increase the risk to develop cognitive or anxiety symptoms, common to brain diseases like dementia and depression in which plasticity changes occur, and a normalization of neurogenesis may be required for a successful treatment response and recovery.

1 April 2009 in Cancer Research
Verified
Journal Article
Closed access
PDF file
DMDavid Maussang
David Maussang
ELEllen Langemeijer
Ellen Langemeijer
CFCarlos P. Fitzsimons
Carlos P. Fitzsimons
MWMarijke Stigter-Van Walsum
Marijke Stigter-Van Walsum
RDRemco Dijkman
Remco Dijkman
MSMartine J. Smit
Martine J. Smit
The human cytomegalovirus (HCMV), potentially associated with the development of malignancies, encodes the constitutively active chemokine receptor US28. Previously, we have shown that US28 expression induces an oncogenic phenotype both in vitro and in vivo. Microarray analysis revealed differential expression of genes involved in oncogenic signaling in US28-expressing NIH-3T3 cells. In particular, the expression of cyclooxygenase-2 (COX-2), a key mediator of inflammatory diseases and major determinant in several forms of cancer, was highly up-regulated. US28 induced increases in COX-2 expression via activation of nuclear factor-κB, driving the production of vascular endothelial growth factor. Also, in HCMV-infected cells, US28 contributed to the viral induction of COX-2. Finally, the involvement of COX-2 in US28-mediated tumor formation was evaluated using the COX-2 selective inhibitor Celecoxib. Targeting COX-2 in vivo with Celecoxib led to a marked delay in the onset of tumor formation in nude mice injected with US28-transfected NIH-3T3 cells and a reduction of subsequent growth by repressing the US28-induced angiogenic activity. Hence, the development of HCMV-related proliferative diseases may partially be ascribed to the ability of US28 to activate COX-2. [Cancer Res 2009;69(7):2861–9]

28 August 2012 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
CFC P Fitzsimons
C P Fitzsimons
LHL W A van Hooijdonk
L W A van Hooijdonk
MSM Schouten
M Schouten
IZI Zalachoras
I Zalachoras
VBV Brinks
V Brinks
EVE Vreugdenhil
E Vreugdenhil

1 October 2009 in Brain Research
Verified
Journal Article
Closed access
RKRon de Kloet
Ron de Kloet
CFC.P. Fitzsimons
C.P. Fitzsimons
NDN.A. Datson
N.A. Datson
Onno C. MeijerOnno C. Meijer
Onno C. Meijer
EVE. Vreugdenhil
E. Vreugdenhil